|
|
|
Volumn 128, Issue 12, 2001, Pages 1291-1294
|
|
Topical tacrolimus in dermatology: What can be expected?;Tacrolimus topique en dermatologie: Que peut-on en attendre?
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
CORTICOSTEROID;
CYCLOSPORIN A;
CYTOKINE;
HYDROCORTISONE;
LYMPHOKINE;
TACROLIMUS;
ATOPIC DERMATITIS;
CYTOKINE PRODUCTION;
CYTOPENIA;
DIABETES MELLITUS;
DRUG ABSORPTION;
DRUG EFFICACY;
DRUG TOLERABILITY;
EDITORIAL;
HUMAN;
HYPERKALEMIA;
HYPERTENSION;
HYPERTROPHIC CARDIOMYOPATHY;
IMMUNOMODULATION;
IMMUNOSUPPRESSIVE TREATMENT;
LYMPHOCYTE ACTIVATION;
LYMPHOPROLIFERATIVE DISEASE;
NEPHROTOXICITY;
PARESTHESIA;
PHOTOTHERAPY;
SKIN ABSORPTION;
STREPTOMYCES TSUKUBAENSIS;
T LYMPHOCYTE ACTIVATION;
ADMINISTRATION, TOPICAL;
ADULT;
ADVERSE DRUG REACTION REPORTING SYSTEMS;
ANIMALS;
AUTOIMMUNE DISEASES;
CHILD;
CLINICAL TRIALS;
DERMATITIS, ATOPIC;
HUMANS;
IMMUNOSUPPRESSIVE AGENTS;
SKIN DISEASES;
TACROLIMUS;
TREATMENT OUTCOME;
|
|
EID: 0035700250
PISSN: 01519638
EISSN: None
Source Type: Journal
DOI: None Document Type: Editorial |
|
Times cited : (1)
|
|
References (8)
|
